A detailed history of Lebenthal Global Advisors, LLC transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Lebenthal Global Advisors, LLC holds 2,865 shares of INSP stock, worth $389,554. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,865
Previous 3,040 5.76%
Holding current value
$389,554
Previous $618,000 0.49%
% of portfolio
0.14%
Previous 0.14%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$165.3 - $226.0 $28,927 - $39,550
-175 Reduced 5.76%
2,865 $615,000
Q4 2023

Feb 07, 2024

SELL
$125.26 - $203.83 $1,878 - $3,057
-15 Reduced 0.49%
3,040 $618,000
Q3 2023

Nov 08, 2023

SELL
$185.0 - $326.08 $4,625 - $8,152
-25 Reduced 0.81%
3,055 $606,000
Q2 2023

Aug 08, 2023

SELL
$226.52 - $324.64 $36,243 - $51,942
-160 Reduced 4.94%
3,080 $999,000
Q1 2023

May 05, 2023

SELL
$229.06 - $278.01 $13,514 - $16,402
-59 Reduced 1.79%
3,240 $758,000
Q4 2022

Feb 06, 2023

SELL
$164.02 - $259.76 $6,724 - $10,650
-41 Reduced 1.23%
3,299 $830,000
Q2 2022

Aug 05, 2022

SELL
$147.53 - $266.6 $14,753 - $26,660
-100 Reduced 2.91%
3,340 $610,000
Q4 2021

Apr 15, 2022

SELL
$207.57 - $280.17 $8,302 - $11,206
-40 Reduced 1.15%
3,440 $791,000
Q4 2021

Feb 15, 2022

SELL
$207.57 - $280.17 $12,454 - $16,810
-60 Reduced 1.69%
3,480 $800,000
Q3 2021

Nov 01, 2021

BUY
$170.0 - $258.58 $68,000 - $103,432
400 Added 12.74%
3,540 $824,000
Q2 2021

Aug 05, 2021

BUY
$164.93 - $242.23 $131,944 - $193,784
800 Added 34.19%
3,140 $606,000
Q1 2021

May 07, 2021

BUY
$182.45 - $249.25 $33,753 - $46,111
185 Added 8.58%
2,340 $484,000
Q4 2020

Feb 12, 2021

BUY
$119.35 - $200.46 $257,199 - $431,991
2,155 New
2,155 $405,000

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $3.91B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Lebenthal Global Advisors, LLC Portfolio

Follow Lebenthal Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lebenthal Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lebenthal Global Advisors, LLC with notifications on news.